Font Sizes: A A A

Sandor Kerpel-Fronius

Sandor Kerpel-Fronius

Sandor Kerpel-Fronius

Present appointment: Scientific advisor

Phone: +36 1 210 29 30/56272

Email:kerpel

Education and qualification:
1958-1964 Semmelweis University, Faculty of Medicine, Budapest, Hungary

Present affiliation:
1999- Semmelweis University, Medical Faculty, Department of Pharmacology and Pharmacotherapy

Previous affiliations and appointments:
Lecturer to Senior Lecturer, Semmelweis Medical University , Department of Anatomy and Histology (1964-1975), Senior Scientist to Head of  the Department of Clinical Pharmacology, National Institute of Oncology (1975-1992), Director of Clinical Oncology – Europe, Sterling Drug Inc., Guildford, UK. (1989-1990), Head of Clinical Oncology (German Speaking Area: Austria, Germany, Switzerland), Farmitalia Carlo Erba GmbH, Pharmacia-Farmitalia, Pharmacia, Germany (1990-2001), Professor of Clinical Pharmacology, Semmelweis University, Department of  Pharmacology and Pharmacotherapy (1999-2010), General Director of the Hungarian  National Institute of Pharmacy (Hungarian Regulatory Agency) (2002-2002), 2010- Scientific Advisor, Semmelweis University, Medical Faculty, Department of Pharmacology and Pharmacotherapy

Scientific degrees:
1972 PhD
1977 Board Certification in Clinical Laboratory Sciences
1979 Board Certification in Clinical Pharmacology
1988 D.Sc.
1995 Dr. Med. Habil.

Educational activities:
Graduate education:
1964-1975 Semmelweis Medical University, Department of Anatomy and Histology Practical teaching and lecturing
1999- Semmelweis University, Department of  Pharmacology and Pharmacotherapy lecturing in clinical pharmacology
2008- Pharmacotherapy seminar, co-leader of the seminar
Postgraduate education (Continuous Professional training):
1975-1992 Tumor chemotherapy education
1991-2017 National GCP courses as part of the continuous professional education 

1999-2017 Head of the Clinical Pharmacologic continuous medical education
2009-2019 Head of the Cooperative European Medicne Development Course (CEMDC) Hungarian Drug Development Pharmaceutical Medicine course as part of the continuous professional education , Semmelweis University
Ingternational educational activities
1980-1989 UICC (Union for International Cancer Control Contra Cancer) International Chemotherapy Training Program

2001-2012 Viennese School of Clinical Research, continuous professional education for clinical investigators
2005- Lyon, Eudipharma, Claude Bernard University, Pharmaceutical Medicine Course
2013- European Course of Pharmaceutical Medicine, Basel, Switzerland
2017- FAPPAcademy, International Internet Based Course on Pharmaceutical Medicine, Module Leader, Lecturer, USA
2017- Visiting Professor, King’s College, Faculty of Pharmaceutical Medicine, London

Major appointments and memberships in professional societies:
1980-1989 Union for International Cancer Control Contra Cancer. Committee of Chemotherapy Training Program, Faculty Member
1980-1989 European Organizationn of the Research and Treatmen of Cancer( EORTC), Member of the Pharmakokinetic and Metabolism Group 

2001- VSCR (Viennese School of Clinical Research)  Counil and Faculty Member
2001- Member of the Hungarian Saint Stephen  Scientific Academy
2001- Hungarian Society of Pharmacology and Pharmacotherapy, Executive Board Member  Head of the Pharmaceutical Medicne Section
2001-2002 Head of the Drug Application Committee Committee of the Hungarian Medical Science Council
2004- Chairman of the Drug Formulary Committee, Semmelweis University
2004-2010 Hungarian Academy of Sciences, Representative of the General Assemly
2005- Lyon, Eudipharma, Claude Bernard University, Pharmaceutical Medicine Course, Faculty Member
2005-EACPT (European Association of Clinical Pharmacology and Therapeutics) Member of EACPT Subcommittee for Education
2007-2008 Chairman of the Hungarian Chemotherapy Society
2007-2010 IFAPP (International Federation of Associations of Pharmaceutical Physicians) Member of the Committee of Education of Pharmaceutical Medicine
2010- IFAPP Member of the Executive Board, Head of the the Working Group on Ethics
2009- IMI-PharmaTrain program (EFCPM, European Federation of Courses in Pharmaceutical Medicine) Memberf of the Executive Board, Head of the Geographical Extension Working Party

Editorial Board Membership
2015- Associate Editor, Frontiers in Pharmacology, Pharmaceutical Medicine and Outcome Research

2016- Associate Editor, Frontiers in Medicine, Regulatory Science
2015- Associate Editor, Journal of Medicines Development Sciences.

Scholarships:
1967-1968 Fellowship, Karolinska Institute, Department of Pharmacology, Stockholm, Sweden
1972-1974 A.P. Sloan Fellowship in Neurobiology, Maryland University, Department of Medicinal Chemistry, Baltimore, U.S.
1974 European Molecular Biology Fellowship, Stockholm University, Department of Biochemistry, Stockholm, Sweden
1984 Fellowship, Free University of Amsterdam, Department of Oncology, Amsterdam, The Netherlands
1987-1988 Sabbatical Year, Wayne State University, Department of Hematology and Oncology, Detroit, U.S.

Awards:
1987 Novicardin price, price given by the hungarian Academy of Sciences
2005 Lege Artis Medicinae (LAM) price given by the Journal
2008 Issekutz price, given by the Hungarian Society of Pharmacology and Pharmacotherapy
2010 Memory Medal of Hungarian Graduate Education
2001 Honorary Member of the Polish Medical Oncology Society

2016 Honorary Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians    of the United Kingdom